Optimizing meropenem in highly resistant Klebsiella pneumoniae environments: population pharmacokinetics and dosing simulations in critically ill patients
AQ Truong, XC Dao, DH Vu, HA Nguyen… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Critically ill patients are characterized by substantial pathophysiological changes that alter
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill Patients
AQ Truong, XC Dao, DH Vu… - Antimicrobial …, 2022 - pubmed.ncbi.nlm.nih.gov
Critically ill patients are characterized by substantial pathophysiological changes that alter
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
Optimizing meropenem in highly resistant Klebsiella pneumoniae environments: population pharmacokinetics and dosing simulations in critically ill patients.
AQ Truong, XC Dao, DH Vu, HA Nguyen, THG Do… - 2022 - cabidigitallibrary.org
Critically ill patients are characterized by substantial pathophysiological changes that alter
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill Patients.
AQ Truong, XC Dao, DH Vu, HA Nguyen… - Antimicrobial Agents …, 2022 - europepmc.org
Critically ill patients are characterized by substantial pathophysiological changes that alter
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
[引用][C] Optimizing meropenem in highly resistant Klebsiella pneumoniae environments: population pharmacokinetics and dosing simulations in critically ill patients
AQ Truong, DH Vu, HA Nguyen… - Antimicrobial …, 2022 - espace.library.uq.edu.au
Critically ill patients are characterized by substantial pathophysiological changes that alter
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
[HTML][HTML] Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill …
AQ Truong, XC Dao, DH Vu, HA Nguyen… - Antimicrobial Agents …, 2022 - ncbi.nlm.nih.gov
Critically ill patients are characterized by substantial pathophysiological changes that alter
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill Patients.
AQ Truong, XC Dao, DH Vu, HA Nguyen… - Antimicrobial Agents …, 2022 - europepmc.org
Critically ill patients are characterized by substantial pathophysiological changes that alter
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …
the pharmacokinetics (PK) of hydrophilic antibiotics, including carbapenems. Meropenem is …